Genomtec S.A. (WSE:GMT)
Poland · Delayed Price · Currency is PLN 4.440
-0.120 (-2.63%)
Jul 21, 2026, 5:00 PM CET
Genomtec Company Description
Genomtec S.A. researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland.
The company’s flagship project is the Genomtec ID, a diagnostic platform that enables the detection of pathogens, such as viruses, bacteria, and fungi, as well as genetic mutations through the analysis of biological material of patients using swabs, urine, and saliva.
It also develops SNAAT chemistry for mutation detection in oncology. In addition, the company develops and commercializes tests used in the detection of viral infectious diseases and other areas.
Genomtec S.A. was founded in 2016 and is based in Wroclaw, Poland.
Genomtec S.A.
| Country | Poland |
| Founded | 2016 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 32 |
| CEO | Miron Tokarski |
Contact Details
Address: Bierutowska Street 57-59 Wroclaw, 51-317 Poland | |
| Phone | 48 793 440 931 |
| Website | genomtec.com |
Stock Details
| Ticker Symbol | GMT |
| Exchange | Warsaw Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PLN |
| ISIN Number | PLGNMTC00017 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Miron Tokarski Ph.D. | Co-Founder, Chief Executive Officer and Member of the Management Board |
| Michal Wachowski | Chief Financial Officer and Member of the Management Board |
| Henryk Roguszczak M.Sc. | Co-founder and Chief Designer |
| Dr. Malgorzata Malodobra-Mazur | Co-founder and Director of Research and Development |
| Lee Huntley | Chief Technology Officer and Member of the Management Board |